Roles of IGF1 signaling in age-related hearing impairment
Project/Area Number |
26462557
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Otorhinolaryngology
|
Research Institution | Kyoto University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
山本 典生 京都大学, 医学研究科, 講師 (70378644)
岡野 高之 京都大学, 医学研究科, 助教 (60642931)
|
Project Period (FY) |
2014-04-01 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2015: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2014: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Keywords | 内耳 / 加齢性難聴 / インスリン様細胞増殖因子1 / 感音難聴 |
Outline of Final Research Achievements |
In the present study, we investigated roles of IGF-1 signaling in the onset of age-related hearing impairment aiming drug development for age-related hearing impairment. We analyzed ages of the onset of age-related hearing impairment in three mouse strains, which have different mechanisms and timing for age-related hearing impairment by means of physiological and morphological assessments. Thereafter, changes in mRNA levels of IGF-1 signaling associated molecules just before the onset of age-related hearing impairment were examined using q-PCR. As results, we determined ages when age-related hearing impairment appear in three strains, and identified changing expression patterns of molecules associated with IGF-1 signaling at the onset of age-related hearing impairment in C57BL6 mice.
|
Report
(4 results)
Research Products
(20 results)
-
-
-
[Journal Article] Prognostic impact of salvage treatment on hearing recovery in patients with sudden sensorineural hearing loss refractory to systemic corticosteroids: A retrospective observational study2015
Author(s)
Nakagawa, T. Yamamoto, M. Kumakawa, K. Usami, S. I. Hato, N. Tabuchi, K. Takahashi, M. Fujiwara, K. Sasaki, A. Komune, S. Yamamoto, N. Hiraumi, H. Sakamoto, T. Shimizu, A. Ito, J.
-
Journal Title
Auris Nasus Larynx
Volume: Online
Issue: 5
Pages: 1-6
DOI
NAID
Related Report
Peer Reviewed
-
-
[Journal Article] A randomized controlled clinical trial of topical insulin-like growth factor-1 therapy for sudden deafness refractory to systemic corticosteroid treatment.2014
Author(s)
Nakagawa T, Kumakawa K, Usami S, Hato N, Tabuchi K, Takahashi M, Fujiwara K, Sasaki A, Komune S, Sakamoto T, Hiraumi H, Yamamoto N, Tanaka S, Tada H, Yamamoto M, Yonezawa A, Ito-Ihara T, Ikeda T, Shimizu A, Tabata Y, Ito J.
-
Journal Title
BMC Med
Volume: 12
Pages: 219-219
NAID
Related Report
Peer Reviewed / Open Access
-
-
-
-
-
[Presentation] Topical IGF-1 therapy for sensorineural hearing loss2016
Author(s)
Takayuki Nakagawa, Norio Yamamoto, Takayuki Okano, Kohei Yamahara, Juichi Ito, Koichi Omori
Organizer
16th JAPAN KOREA Joint Meeting of Otorhinolaryngology-Head and Neck Surgery
Place of Presentation
Hyatt Regency(Tokyo, Japan)
Year and Date
2016-03-29
Related Report
Int'l Joint Research
-
-
-
-
-
-
[Presentation] A Randomized Controlled Clinical trial of Topical IGF-1 Therapy via Gelatin Hydrogels for Refractory Sudden Sensorineural Hearing Loss.2015
Author(s)
Nakagawa T, Kumakawa K, Usami S, Hato N, Tabuchi K, Takahashi M, Fujiwara K, Sasaki A, Komune S, Sakamoto T, Hiraumi H, Yamamoto N, Tanaka S, Tada H, Yamamoto M, Yonezawa A, Ito-Ihara T, Ikeda T, Shimizu A, Tabata Y, Ito J
Organizer
ARO 38th Annual MidWinter Meeting
Place of Presentation
Baltimore MA USA
Year and Date
2015-02-21 – 2015-02-25
Related Report
-
-
-
-